Search
for

    Sort by

    Research 661–690 of 1000+

    1. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    2. Anabolic effects of testosterone are preserved during inhibition of 5α-reductase 2007 · 42 citations
    3. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 41 citations
    4. Antiandrogens: Clinical applications The Journal of Steroid Biochemistry and Molecular Biology · 1990 · 39 citations
    5. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients Cell Transplantation · 2020 · 38 citations
    6. Recent advances in thiasteroids chemistry Steroids · 2006 · 37 citations
    7. Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period The Journal of Urology · 2006 · 32 citations
    8. The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic Frontiers in Endocrinology · 2021 · 29 citations
    9. Effects of lifelong testosterone exposure on health and disease using Mendelian randomization eLife · 2020 · 29 citations
    10. CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism? The Journal of Sexual Medicine · 2013 · 29 citations
    11. Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids Endocrine, metabolic & immune disorders. Drug targets · 2006 · 26 citations
    12. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    13. Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry 2017 · 22 citations
    14. Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-<i>N</i>-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors Journal of Medicinal Chemistry · 2002 · 22 citations
    15. Disease Versus Disease: How One Disease May Ameliorate Another Pediatrics · 2006 · 21 citations
    16. Meta-Analysis of Randomized Clinical Trials of Finasteride Urology · 1998 · 21 citations
    17. Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i> Chemistry & Biodiversity · 2009 · 20 citations
    18. Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · 2007 · 20 citations
    19. Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors Current Medicinal Chemistry · 2005 · 20 citations
    20. FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 17 citations
    21. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    22. Does Finasteride Have a Preventive Effect on Chronic Bacterial Prostatitis? Pilot Study Using an Animal Model Urologia Internationalis · 2011 · 14 citations
    23. Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium(III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist Tetrahedron Letters · 1994 · 14 citations
    24. New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide) Steroids · 2005 · 14 citations
    25. Finasterida: Diez Años De Uso Clínico. Revisión Sistemática De La Literatura Actas Urológicas Españolas · 2003 · 14 citations
    26. Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency Endocrine journal · 2019 · 13 citations
    27. PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice Canadian Urological Association Journal · 2012 · 13 citations
    28. Synthesis and Pharmacological Evaluation of New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors Chemical and Pharmaceutical Bulletin · 2005 · 13 citations
    29. Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients European Urology Supplements · 2003 · 12 citations
    30. Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens Journal of Medicinal Chemistry · 1995 · 12 citations